Monica Patten

4.8k total citations
47 papers, 1.3k citations indexed

About

Monica Patten is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Monica Patten has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Monica Patten's work include Cardiomyopathy and Myosin Studies (20 papers), Cardiac Arrhythmias and Treatments (10 papers) and Cardiovascular Effects of Exercise (9 papers). Monica Patten is often cited by papers focused on Cardiomyopathy and Myosin Studies (20 papers), Cardiac Arrhythmias and Treatments (10 papers) and Cardiovascular Effects of Exercise (9 papers). Monica Patten collaborates with scholars based in Germany, United States and United Kingdom. Monica Patten's co-authors include Carlin S. Long, Wendy Hartogensis, F. David Fortuin, James N. Palmer, Julia Münch, Maxim Avanesov, Gunnar Lund, Lucie Carrier, Mark S. Paller and Enver Tahir and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Monica Patten

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica Patten Germany	21	863	463	112	111	105	47	1.3k
Elke Dworatzek Germany	19	718 0.8×	345 0.7×	140 1.3×	54 0.5×	137 1.3×	28	1.4k
Haruhito Harada Japan	19	493 0.6×	641 1.4×	165 1.5×	84 0.8×	88 0.8×	46	1.4k
James K. Hennan United States	21	675 0.8×	642 1.4×	117 1.0×	41 0.4×	123 1.2×	45	1.4k
Harry A.J. Struijker Boudier Netherlands	14	435 0.5×	303 0.7×	170 1.5×	76 0.7×	90 0.9×	27	967
Hidetaka Kioka Japan	16	353 0.4×	281 0.6×	70 0.6×	186 1.7×	145 1.4×	49	879
Haiyi Yu China	17	375 0.4×	442 1.0×	76 0.7×	37 0.3×	134 1.3×	52	986
Gregory S. Friedrichs United States	18	463 0.5×	298 0.6×	58 0.5×	41 0.4×	107 1.0×	50	948
Elizabeth C. LeRoy United States	14	400 0.5×	257 0.6×	80 0.7×	132 1.2×	41 0.4×	21	1.1k
Carmen Brás‐Silva Portugal	19	683 0.8×	292 0.6×	237 2.1×	81 0.7×	179 1.7×	63	1.2k
Halfdan Aass Norway	21	1.3k 1.5×	674 1.5×	126 1.1×	81 0.7×	181 1.7×	53	1.8k

Countries citing papers authored by Monica Patten

Since Specialization

Citations

This map shows the geographic impact of Monica Patten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Patten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Patten more than expected).

Fields of papers citing papers by Monica Patten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Patten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Patten. The network helps show where Monica Patten may publish in the future.

Co-authorship network of co-authors of Monica Patten

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Patten. A scholar is included among the top collaborators of Monica Patten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Patten. Monica Patten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suling, Anna, Ersin Çavuş, Kai Muellerleile, et al.. (2022). Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy. Life. 12(8). 1241–1241. 7 indexed citations

Dinshaw, Leon, Paula Münkler, Benjamin Schäffer, et al.. (2021). Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long‐Term Outcome. Journal of the American Heart Association. 10(3). e017451–e017451. 24 indexed citations

Çavuş, Ersin, Kai Muellerleile, Enver Tahir, et al.. (2021). CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy. Clinical Research in Cardiology. 110(11). 1757–1769. 19 indexed citations

Krämer, Elisabeth, Frederik Flenner, Giulia Mearini, et al.. (2019). Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue. Frontiers in Physiology. 10. 239–239. 10 indexed citations

Tahir, Enver, Jitka Starekova, Kai Muellerleile, et al.. (2017). Myocardial Fibrosis in Competitive Triathletes Detected by Contrast-Enhanced CMR Correlates With Exercise-Induced Hypertension and Competition History. JACC. Cardiovascular imaging. 11(9). 1260–1270. 110 indexed citations

Prondzynski, Maksymilian, Elisabeth Krämer, Sandra D. Laufer, et al.. (2017). Evaluation of MYBPC3 trans -Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes. Molecular Therapy — Nucleic Acids. 7. 475–486. 71 indexed citations

Dinshaw, Leon, Julia Münch, Jannis Dickow, et al.. (2017). The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy. Clinical Research in Cardiology. 107(2). 130–137. 14 indexed citations

Avanesov, Maxim, Julia Münch, Julius Matthias Weinrich, et al.. (2017). Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR. European Radiology. 27(12). 5136–5145. 53 indexed citations

Münch, Julia, et al.. (2016). Influence of RAAS inhibition on outflow tract obstruction in hypertrophic cardiomyopathy. Cardiovascular Medicine. 19(5). 152–156. 1 indexed citations

10.

d’Amati, Giulia, Cristina Basso, Albert C. van Rossum, et al.. (2015). Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations. Cardiovascular Research. 105(4). 409–423. 45 indexed citations

11.

Friedrich, Felix W., Silke Reischmann, Andreas Unger, et al.. (2014). FHL2 expression and variants in hypertrophic cardiomyopathy. Basic Research in Cardiology. 109(6). 451–451. 54 indexed citations

12.

Wieland, Thomas, et al.. (2007). Sphingosine-1-phosphate and endothelin-1 induce the expression of rgs16 protein in cardiac myocytes by transcriptional activation of the rgs16 gene. Naunyn-Schmiedeberg s Archives of Pharmacology. 376(5). 363–373. 17 indexed citations

13.

Patten, Monica, et al.. (2006). Event‐Recorder Monitoring in the Diagnosis of Atrial Fibrillation in Symptomatic Patients: Subanalysis of the SOPAT Trial. Journal of Cardiovascular Electrophysiology. 17(11). 1216–1220. 76 indexed citations

14.

Patten, Monica. (2005). Asymptomatisches Vorhofflimmern bei systematischem Screening mittels Tele-EKG: —Bedeutung für die Antikoagulation bei paroxysmalem Vorhofflimmern. Herzschrittmachertherapie + Elektrophysiologie. 16(3). 159–164.

15.

Patten, Monica & T. Meinertz. (2005). Medikamentöse antiarrhythmische Therapie - aktuelle Aspekte. DMW - Deutsche Medizinische Wochenschrift. 130(21). 1325–1329. 1 indexed citations

16.

Patten, Monica. (2002). Endotoxin induces desensitization of cardiac endothelin-1 receptor signaling by increased expression of RGS4 and RGS16. Cardiovascular Research. 53(1). 156–164. 31 indexed citations

17.

Patten, Monica, et al.. (2000). IL-1 β Increases Abundance and Activity of the Negative Transcriptional Regulator Yin Yang-1 (YY1) in Neonatal Rat Cardiac Myocytes. Journal of Molecular and Cellular Cardiology. 32(7). 1341–1352. 24 indexed citations

18.

Patten, Monica, Wendy Hartogensis, & Carlin S. Long. (1996). Interleukin-1β Is a Negative Transcriptional Regulator of α1-Adrenergic Induced Gene Expression in Cultured Cardiac Myocytes. Journal of Biological Chemistry. 271(35). 21134–21141. 49 indexed citations

19.

Jakob, Heinz, Thomas Eschenhagen, Ulrike Mende, et al.. (1995). Effect of captopril on myocardial ?-adrenoceptor density and Gi?-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy. European Journal of Clinical Pharmacology. 47(5). 389–94. 11 indexed citations

20.

Scholz, Jens, et al.. (1991). Maligne Hyperthermie und Inositolphosphat-Stoffwechsel in Herz- und Skelettmuskulatur. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 26(8). 450–453. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact